ARCUTIS BIOTHERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2022-02-22
- ARCUTIS BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2020-12-31 was $0.00.
- ARCUTIS BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2020-09-30 was $0.00.
- ARCUTIS BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2020-06-30 was $0.00.
- ARCUTIS BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- ARCUTIS BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2021 was $0.00.
- ARCUTIS BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ARCUTIS BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2019 was $47.00K.
- ARCUTIS BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-22 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $0.00 10-K · filed 2022-02-22 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $0.00 10-Q · filed 2020-08-11 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $0.00 derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $0.00 derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $47.00K 10-K · filed 2022-02-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $47.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $47.00K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $47.00K 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |